Ivan King, PhD, MD

Dr. Ivan King is currently the executive vice president of Clinical Operations at Hinova
Pharmaceuticals, Inc. He was previously the Chief Technology Officer of CL Precision Biomed, a
subsidiary of Cheerland Investment Group, and the Senior VP of Pre-Clinical Development and
Quality Assurance at BeiGene (Beijing), Ltd. Prior to joining BeiGene, he held positions as Vice
President of Research and Development at Vion Pharmaceuticals, Inc., Section Leader at the
Schering-Plough Research Institute, and Senior Scientist at Bristol Myers Squibb. Dr. King has
been working on the discovery and development of oncology products for more than thirty
years, with over twenty years in the pharmaceutical industry. He has co-authored more than fifty
manuscripts and book chapters, and is a co-inventor for over forty US and world patents. Dr.
King received his Ph.D. from the University of Texas at Houston, his M.D. at Anderson Cancer
Center and completed his postdoctoral training at Yale University.
Speaking In
2:15 PM - 3:15 PM (PDT)
Monday, June 13
Learn the latest about biomedical innovation within the China biotech community from this showcase…